PLEXTOPIA Trademark

Trademark Overview


On Thursday, December 11, 2003, a trademark application was filed for PLEXTOPIA with the United States Patent and Trademark Office. The USPTO has given the PLEXTOPIA trademark a serial number of 78339460. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 5, 2012. This trademark is owned by Glaxo Group Limited. The PLEXTOPIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue
plextopia

General Information


Serial Number78339460
Word MarkPLEXTOPIA
Filing DateThursday, December 11, 2003
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 5, 2012
Registration Number3044468
Registration DateTuesday, January 17, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2005

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 5, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMiddlesex UB6 0NN
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMiddlesex UB6 0NN
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiddlesex UB6 0NN
GB

Trademark Events


Event DateEvent Description
Friday, October 5, 2012CANCELLED SEC. 8 (6-YR)
Wednesday, May 12, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 9, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 9, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 17, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, October 25, 2005PUBLISHED FOR OPPOSITION
Wednesday, October 5, 2005NOTICE OF PUBLICATION
Monday, July 11, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, July 1, 2005ASSIGNED TO LIE
Friday, May 20, 2005ASSIGNED TO LIE
Friday, May 20, 2005ASSIGNED TO LIE
Thursday, April 21, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 21, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 31, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 31, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 5, 2004NON-FINAL ACTION E-MAILED
Tuesday, October 5, 2004NON-FINAL ACTION WRITTEN
Tuesday, September 21, 2004ASSIGNED TO EXAMINER
Tuesday, July 6, 2004ASSIGNED TO EXAMINER
Tuesday, January 6, 2004NEW APPLICATION ENTERED IN TRAM